Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic.
Cirrhosis
Italy
S. pneumoniae
Vaccine
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
07
10
2022
accepted:
26
04
2023
medline:
17
7
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
To date, few reports have evaluated the pneumococcal vaccination status in cirrhotic patients. No data are available for European countries. We have explored this topic and the potential independent predictors motivating lack of vaccination in Italy. Between January 1
Identifiants
pubmed: 37169944
doi: 10.1007/s10096-023-04614-9
pii: 10.1007/s10096-023-04614-9
doi:
Substances chimiques
Pneumococcal Vaccines
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
945-950Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Albillos A, Lario M, Alvarez-Moh M (2014) Cirrhosis associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 61:1385–1396
doi: 10.1016/j.jhep.2014.08.010
pubmed: 25135860
Hung TH, Tseng CW, Hsieh YH et al (2013) High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterol 13:25
doi: 10.1186/1471-230X-13-25
pubmed: 23390924
pmcid: 3599048
Arvaniti V, D’Amico G, Fede G et al (2010) Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 139:1246–1256
doi: 10.1053/j.gastro.2010.06.019
pubmed: 20558165
Christon L, Pappas G, Falagas ME (2007) Bacterial infection related morbidity and mortality in cirrhosis. Amer J Gastroenterol 102:1510–1517
doi: 10.1111/j.1572-0241.2007.01286.x
Tandon P, Garcia-Tsao G (2008) Bacterial infections, sepsis and multiorgan failure in cirrhosis. Semin Liver Dis 28:26–42
doi: 10.1055/s-2008-1040319
pubmed: 18293275
Jain S, Self WH, Wunderink RG et al (2015) Community acquired pneumonia requiring hospitalization among adults. N Engl J Med 373:415–427
doi: 10.1056/NEJMoa1500245
pubmed: 26172429
pmcid: 4728150
Viasus D, Garcia-Vidal C, Castellote J et al (2011) Community acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity score. Medicine 90:110–118
doi: 10.1097/MD.0b013e318210504c
pubmed: 21358441
Gil-Prieto R, Pascual-Garcia R, Walter S et al (2016) Risk of hospitalization due to pneumococcal disease in adults in Spain. The Corienne Study Human Vaccin Immunother 2:1900–1905
Feikin D, Schuchat A, Kolczak M et al (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 90:223–229
doi: 10.2105/AJPH.90.2.223
pubmed: 10667183
pmcid: 1446155
Italian Ministry of Health. National immunization plan (2017-2019) https://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?id=25712021 . Accessed 13 Apr
Jacobs RJ, Meyerhoff AS, Saab S (2005) Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci 50:1525–1531
doi: 10.1007/s10620-005-2873-5
pubmed: 16110847
Ahmmad EM, Roberts LR (2020) Quality of care in patients with cirrhosis: trends in recommended adult vaccination coverage. Mayo Clin Proc Innov Qual Outcomes 4:667–682
doi: 10.1016/j.mayocpiqo.2020.06.007
pubmed: 33367212
pmcid: 7749261
Gaiani S, Gramantieri L, Venturoli N et al (1997) What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 27:979–985
doi: 10.1016/S0168-8278(97)80140-7
pubmed: 9453422
Chon YE, Choi EH, Song KJ et al (2012) Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One 7:e44930
doi: 10.1371/journal.pone.0044930
pubmed: 23049764
pmcid: 3458028
Stroffolini T, Sagnelli E, Gaeta GB et al (2017) Characteristics of liver cirrhosis in Italy: evidence for a decreasing role of HCV aetiology. Eur J Intern Med 38:68–72
doi: 10.1016/j.ejim.2016.10.012
pubmed: 27836249
Cheruvattath R, Balan V (2007) Infectious in patients with end-stage liver disease. J Clin Gastroenterol 41:403–411
doi: 10.1097/01.mcg.0000248018.08515.f9
pubmed: 17413611
Propst-Graham KL, Preheim LC, Vander Top EA et al (2007) Cirrhosis-induced defects in innate pulmonary defenses against Steptococcus Pneumoniae. Microbiol 7:94
Mccashland TM, Preheim LC, Gentry MJ (2000) Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 181:757–760
doi: 10.1086/315245
pubmed: 10669371
Harmala S, Parisinos CA, Shallcross L et al (2019) Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ Open 9:031070
doi: 10.1136/bmjopen-2019-031070
Aggeletopoulou I, Davoulou P, Konstantakis C et al (2017) Response to hepatitis B vaccination in patients with liver cirrhosis. Rev Med Virol 27:e1942
doi: 10.1002/rmv.1942
Leise MD, Talwalkar JA (2013) Immunizations in chronic liver disease: what should be done and what is the evidence. Curr Gastroenterol Rep 15:300–306
doi: 10.1007/s11894-012-0300-6
pubmed: 23250700